Chris is currently a postdoctoral scholar in CEDAR at OHSU and at the Early Cancer Institute at University of Cambridge in Jamie Blundell’s lab. His work is funded through an Early Career Pathway Award from the International Alliance for Cancer Early Detection’s (ACED). Chris earned his BA in Biochemistry and Molecular Biology from Reed College in Portland, Oregon, USA. He obtained his PhD in Cancer Biology and Early Detection from OHSU, where he developed novel molecular barcoding techniques and computational error-modelling approaches to detect low-abundance mutations in DNA using next-generation sequencing of early- and late-stage cancer patients. Currently, his work in Dr. Blundell’s lab is focused on detecting and characterizing pre-cancerous clonal expansions in hematological malignancies using DNA methylation.

When he's not in the lab or in the data, Chris enjoys travelling and exploring the beautiful Pacific Northwest with his wife, Emily, and two lovely children.